01 1Merck Sharp & Dohme LLC
01 1IMIPENEM ANHYDROUS, cilastatin, and RELEBACTAM ANHYDROUS
01 1U.S.A
CILASTATIN; IMIPENEM ANHYDROUS; RELEBACTAM ANHYDROUS
NDC Package Code : 0006-0138
Start Marketing Date : 2020-01-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SOLUTION (500mg/100mL 500mg/100mL 250mg/100mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
LOOKING FOR A SUPPLIER?